Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The present study was designed to investigate the protective efficacy of eugenol against skin cancer and probe into the mechanistic aspects. Skin tumors were initiated by applying 160 nmol DMBA and promoted by twice weekly applications of 8.5 nmol TPA for 28 wk. All mice developed tumors by 13 wk of promotion. However, in mice pretreated with 30 µL eugenol, no tumors were detected until 8 wk (following anti‐initiation protocol) and until 14 wk (following antipromotion protocol) of tumor promotion. PCNA and TUNEL immunohistochemistry of tumors revealed eugenol to ameliorate cell proliferation and elevate apoptosis respectively. The effect of eugenol was assessed on specific stages of carcinogenesis. Initiation with DMBA led to a significant upregulation of p53 expression with a concomitant increase in p21 WAF1 levels in epidermal cells indicating induction of damage to the DNA. However, pretreatment with eugenol led to overexpression of these genes, which probably helped stimulate apoptosis of the initiated cells. To ascertain the molecular mechanisms implicated in the antitumor promoting activity of eugenol, its effect was investigated on markers of tumor promotion and inflammation: ODC activity and iNOS and COX‐2 expression, and on levels of proinflammatory cytokines (IL‐6, TNF‐α, and PGE 2). Eugenol markedly inhibited all. Eugenol also inhibited the upstream signaling molecule: NF‐κB, which regulates the expression of these genes. TPA‐induced depletion of cutaneous GSH and antioxidant enzymes armory was also precluded by eugenol. From these results, it could be concluded that eugenol markedly protects against chemically induced skin cancer and acts possibly by virtue of its antiproliferative, anti‐inflammatory, and antioxidant activities. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer chemoprevention with dietary phytochemicals
Surh, Y.-J. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1189 · Cited by 2,955 · cited 1×
“amend the expression and/or activity of intracellular signaling proteins implicated in tumor promotion thereby averting tumorigenesis [32].”
BackgroundOxidative Stress in the Pathogenesis of Skin Disease
Bickers, D. R., & Athar, M. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700340 · Cited by 1,092
Self-citationCellular aspects of photocarcinogenesis
Nishigori, C. (2006) · Photochemical & Photobiological Sciences · doi:10.1039/b507471a · Cited by 161
Lee, Y.-Y., Hung, S.-L., Pai, S.-F., Lee, Y.-H., & Yang, S.-F. (2007) · Journal of Endodontics · doi:10.1016/j.joen.2007.02.010 · Cited by 87 · cited 4×
“However, the same authors have shown eugenol to inhibit COX-2 expression in human macrophages (U937) primed with LPS [46].”
BackgroundInfluential
Cited by
The Potential of Plant Phenolics in Prevention and Therapy of Skin Disorders
Działo, M., Mierziak, J., Korzun, U., Preisner, M., Szopa, J., & Kulma, A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020160 · Cited by 680
Targeting arachidonic acid pathway by natural products for cancer prevention and therapy
Yarla, N. S., Bishayee, A., Sethi, G., Reddanna, P., Kalle, A. M., Dhananjaya, B. L., Dowluru, K. S. V. G. K., Chintala, R., & Duddukuri, G. R. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.02.001 · Cited by 364
Chronic diseases, inflammation, and spices: how are they linked?
Kunnumakkara, A. B., Sailo, B. L., Banik, K., Harsha, C., Prasad, S., Gupta, S. C., Bharti, A. C., & Aggarwal, B. B. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1381-2 · Cited by 344
An Overview on the Anti‐inflammatory Potential and Antioxidant Profile of Eugenol
Barboza, J. N., da Silva Maia Bezerra Filho, C., Silva, R. O., Medeiros, J. V. R., & de Sousa, D. P. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3957262 · Cited by 343
Moringa oleifera as an Anti-Cancer Agent against Breast and Colorectal Cancer Cell Lines
Al-Asmari, A. K., Albalawi, S. M., Athar, M. T., Khan, A. Q., Al-Shahrani, H., & Islam, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0135814 · Cited by 340
Self-citationPharmacological Properties and Health Benefits of Eugenol: A Comprehensive Review
Nisar, M. F., Khadim, M., Rafiq, M., Chen, J., Yang, Y., & Wan, C. C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/2497354 · Cited by 283
Eugenol: A Natural Compound with Versatile Pharmacological Actions
Pramod, K., Ansari, S. H., & Ali, J. (2010) · Natural Product Communications · doi:10.1177/1934578x1000501236 · Cited by 278
Cancer cell signaling pathways targeted by spice-derived nutraceuticals
Sung, B., Prasad, S., Yadav, V. R., & Aggarwal, B. B. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.630551 · Cited by 204
Lesgards, J., Baldovini, N., Vidal, N., & Pietri, S. (2014) · Phytotherapy Research · doi:10.1002/ptr.5165 · Cited by 156
Herbs that heal: Nature’s pharmacy endowed remedies for better health
Mehrotra, N. (2021) · Annals of Phytomedicine: An International Journal · doi:10.21276/ap.2021.10.1.2 · Cited by 27
Metadata
- Authors
- Kaur, G., Athar, M., & Alam, M. S.
- Venue
- Molecular Carcinogenesis
- Publisher
- Wiley
- Published
- 2009-12-30
- Volume
- 49
- Issue
- 3
- Pages
- 290-301
- ISSN
- 0899-1987 (ISSN-L)
- 1098-2744
- OpenAlex
- W1983288937
- Cited by
- 156
- References
- 4
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.